相似文献
1
The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma.
Int J Hepatol. 2011;2011:416459. doi: 10.4061/2011/416459. Epub 2011 May 30.
2
Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
World J Gastroenterol. 2015 Jul 21;21(27):8249-55. doi: 10.3748/wjg.v21.i27.8249.
3
HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12.
4
Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
Am J Surg. 2020 Apr;219(4):717-725. doi: 10.1016/j.amjsurg.2019.05.016. Epub 2019 Jun 13.
5
Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review).
Oncol Lett. 2015 Feb;9(2):527-534. doi: 10.3892/ol.2014.2727. Epub 2014 Nov 21.
6
Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
J Hepatobiliary Pancreat Sci. 2012 Nov;19(6):685-96. doi: 10.1007/s00534-011-0489-z.
7
Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):251-5. doi: 10.1016/s1499-3872(13)60041-7.
8
Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
Ann Surg. 2013 Mar;257(3):490-505. doi: 10.1097/SLA.0b013e318262b218.
9
Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.
JAMA Surg. 2018 Oct 1;153(10):e182721. doi: 10.1001/jamasurg.2018.2721. Epub 2018 Oct 17.
10
Timing of antiviral therapy in patients with hepatitis B virus related hepatocellular carcinoma undergoing hepatectomy.
World J Clin Oncol. 2024 Sep 24;15(9):1251-1255. doi: 10.5306/wjco.v15.i9.1251.
引用本文的文献
1
Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy.
Front Oncol. 2021 Feb 1;10:582504. doi: 10.3389/fonc.2020.582504. eCollection 2020.
2
Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma.
BMC Cancer. 2017 May 2;17(1):304. doi: 10.1186/s12885-017-3293-6.
3
Risk factors for early mortality after hepatectomy for hepatocellular carcinoma.
Medicine (Baltimore). 2016 Sep;95(39):e5028. doi: 10.1097/MD.0000000000005028.
4
Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
World J Gastroenterol. 2016 Mar 28;22(12):3404-11. doi: 10.3748/wjg.v22.i12.3404.
5
Perspective of laparoscopic liver resection for hepatocellular carcinoma.
World J Gastrointest Surg. 2015 Jul 27;7(7):102-6. doi: 10.4240/wjgs.v7.i7.102.
6
Hepatitis B viral load affects prognosis of hepatocellular carcinoma.
World J Gastroenterol. 2014 Sep 14;20(34):12039-44. doi: 10.3748/wjg.v20.i34.12039.
7
Hepatocellular carcinoma: important biomarkers and their significance in molecular diagnostics and therapy.
Curr Med Chem. 2012;19(22):3722-9. doi: 10.2174/092986712801661059.
本文引用的文献
1
Chronic hepatitis B: past, present, and future.
Clin Liver Dis. 2010 Aug;14(3):531-46. doi: 10.1016/j.cld.2010.05.003. Epub 2010 Jun 14.
2
Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis.
World J Gastroenterol. 2010 Jun 21;16(23):2931-42. doi: 10.3748/wjg.v16.i23.2931.
3
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.
J Hepatol. 2009 Nov;51(5):890-7. doi: 10.1016/j.jhep.2009.07.009. Epub 2009 Jul 23.
4
A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection.
Ann Surg Oncol. 2010 Jan;17(1):179-85. doi: 10.1245/s10434-009-0694-z. Epub 2009 Aug 29.
5
Chronic hepatitis B: update 2009.
Hepatology. 2009 Sep;50(3):661-2. doi: 10.1002/hep.23190.
6
Role of viral factors in the natural course and therapy of chronic hepatitis B.
Hepatol Int. 2007 Dec;1(4):415-30. doi: 10.1007/s12072-007-9033-2. Epub 2007 Oct 12.
7
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update.
Hepatol Int. 2008 Sep;2(3):263-83. doi: 10.1007/s12072-008-9080-3. Epub 2008 May 10.
8
Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment.
Cleve Clin J Med. 2009 May;76 Suppl 3:S6-9. doi: 10.3949/ccjm.76.s3.02.
9
Molecular profiling to predict hepatocellular carcinoma outcome.
Expert Rev Gastroenterol Hepatol. 2009 Apr;3(2):101-3. doi: 10.1586/egh.09.5.
10
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing.
Nat Biotechnol. 2009 Feb;27(2):182-9. doi: 10.1038/nbt.1523. Epub 2009 Feb 1.
Zotero 插件